DOAJ
Open Access
2023
P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY
M. Offidani
S. Morè
M. Cavo
D. Derudas
F. Di Raimondo
+17 lainnya
Topik & Kata Kunci
Penulis (22)
M
M. Offidani
S
S. Morè
M
M. Cavo
D
D. Derudas
F
F. Di Raimondo
A
A. Cuneo
L
L. Baldini
R
R. Della Pepa
M
M. Musso
M
M. Boccadoro
P
P. Musto
A
A. Belotti
F
F. Fioritoni
N
N. Di Renzo
A
A. Mele
B
B. Gamberi
L
L. De Paoli
R
R. Zambello
S
S. Grammatico
M
M. Brociner
F
F. Fazio
M
M. T. Petrucci
Format Sitasi
Offidani, M., Morè, S., Cavo, M., Derudas, D., Raimondo, F.D., Cuneo, A. et al. (2023). P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY. https://doi.org/10.1097/01.HS9.0000936272.88286.72
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →Informasi Jurnal
- Tahun Terbit
- 2023
- Sumber Database
- DOAJ
- DOI
- 10.1097/01.HS9.0000936272.88286.72
- Akses
- Open Access ✓